Cll drugs

GAZYVA (obinutuzumab) is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment.

Chronic lymphocytic leukaemia (CLL) Chronic lymphocytic leukaemia (CLL) is a type of blood cancer. It affects the blood and bone marrow. CLL affects the white blood cells called

See what to expect with the stages of chronic lymphocytic leukemia or CLL and how it is treated. Chronic lymphocytic leukemia, CLL Staging, Watch and Wait, Chemotherapy and Drug Therapy

They work by targeting proteins on the surface of cancer cells. The B-cell receptor is a protein found on the surface of CLL cells. It controls how CLL cells grow. If the B-cell receptor is switched off, the CLL cells die. BCR inhibitors target the B-cell receptors to stop the cancer growing and dividing. The drugs that can be used for CLL are:

treatment-naïve CLL in addition to updated data of the drug in CLL. Aside from the company's anti-CD20 drugs, findings from several other

The CLL pipeline drugs market research report provides comprehensive information on the therapeutics under development for CLL

CLL is a slow-growing blood cancer that may not need treatment at first. When it does need treatment, there are many effective drugs that can keep the CLL

Chronic lymphocytic leukemia (CLL) is a chronic (long-term, slowly developing) leukemia. New drugs are in development for people with CLL that target cellular

Rituxan is a drug that was approved for CLL almost 10 years ago. Ibrutinib has been around for a few years and was first approved for CLL treatment in 2024.